ORAFTI to Unveil Key Research Showing Beneo(TM) Oligofructose Can Help Control Obesity

August 3, 2006

2 Min Read
ORAFTI to Unveil Key Research Showing Beneo(TM) Oligofructose Can Help Control Obesity

November 14-16 2006 at Health Ingredients Europe, ORAFTI Booth H20, Hall 3, Frankfurt, Germany

July 31, 2006 (Malvern, PA) - ORAFTI Active Food Ingredients, the world market leader for inulin, will attend this year’s HIE in Frankfurt, Germany, to present their research of a recently published human volunteer study. The breakthrough findings demonstrate that when Beneo™ oligofructose is incorporated into the diet, it can limit hunger feelings and food intake.


The European Association for the study of Obesity* has revealed that approximately one in three people living in the European Union is overweight. Of those 33%, more than one in ten is now obese. Obesity is strongly linked with the incidence of several chronic diseases including diabetes and cardiovascular disease. Subsequently, this has an impact on health care budgets globally. To combat this growing problem, the food industry, has actively been looking for ways to help people achieve a healthy body weight and manage their weight and through their diets. Many of the current weight control strategies have proved ineffective. ORAFTI’s prebiotic ingredients, offer an alternative approach that could help people control their food intake.

Animal & Human Studies

Both animal and the most recent human studies have provided a strong rationale to propose Beneo™ oligofructose supplements in the management of food and food intake. Following animal studies in 2005 it was found that through the administration of BeneoTMP95 and BeneoTMSynergy1, food intake and body weight were modulated in animals. To build on these findings, ORAFTI recently commissioned a human volunteer study to determine the effects of Beneo™ oligofructose on appetite and food intake in humans. The study found that oligofructose (BeneoTMP95) treatment increases satiety, reduces hunger, prospective food consumption and food intake.

Dr. Anne Franck, Executive Vice President of Science and Technology at ORAFTI, commented, “The increase of satiety by Beneo™ oligofructose offers an interesting approach to manage body weight and help tackle the obesity problem. BeneoTM oligofructose should allow food manufacturers to increase the satiety potential of their food products, thus helping consumers avoid overeating.

To find out more on these latest findings, visit ORAFTI at Hall 3, Booth H20

* Report March 2005, www.easoobesity.org

- ### -

About ORAFTI Group

ORAFTI Group is a subsidiary of the Belgian agro-food group Raffinerie Tirlemontoise/ Tiense Suikerraffinaderij and is part of the ORAFTI/ PALATINIT Ingredients business unit of Südzucker Group (Germany).

ORAFTI Group produces Beneo™ inulin and oligofructose for human and animal nutrition, as well as Raftisweet® (fructose syrups), from chicory roots. The ORAFTI Group also includes REMY INDUSTRIES, world leading producer of rice starches (Remy®/Remyline®/Remygel®), rice flours (Remyflo®) and rice proteins (Remypro®).

ORAFTI Group's head office is in Tienen, Belgium. The company operates in more than 75 countries world wide, with production units in Oreye (Belgium), Pemuco (Chile), Wijchen (Netherlands) and Wijgmaal (Belgium).

For more business information:

Joe O’Neill
101 Lindenwood Drive
Malvern, PA 19355

Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like